Tocilizumab in patients with severe COVID-19: a retrospective cohort study
University of Modena and Reggio Emilia · Azienda Ospedaliero-Universitaria di Modena · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
996
total citations
- FWCI
- 24.09
- Percentile
- 100%
- References
- 37
Citations per year
Authors
34- GGGiovanni GuaraldiCorresponding
University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena
- MMMarianna Meschiari
Azienda Ospedaliero-Universitaria di Modena
- ACAlessandro Cozzi‐Lepri
University College London
- JMJovana Milić
University of Modena and Reggio Emilia
- RTRoberto Tonelli
University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena
Topics & keywords
Topics
Keywords
- Tocilizumab
- Coronavirus disease 2019 (COVID-19)
- Medicine
- Retrospective cohort study
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- 2019-20 coronavirus outbreak
- Cohort
- Virology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.